ARTICLE | Clinical News
Treakisym bendamustine regulatory update
November 8, 2010 8:00 AM UTC
SymBio said Japan's Ministry of Health, Labor and Welfare approved an NDA for Treakisym bendamustine to treat refractory/relapsed low-grade non-Hodgkin's lymphoma (NHL) and mantle cell lymphoma (MCL)....